EAACI Congress 2025
BackTPS40 - Immune deficiencies and autoimmunity 02
Saturday 14 Jun, 12:00 PM -
13:00 PM Glasgow, United Kingdom
Poster Zone
Thematic Poster Session
A Complex Case of Hyper-IgE Syndrome with Multisystem Involvement and Potential IL6ST Gene Mutation
A high prevalence of autoimmune diseases and autoantibodies in patients with hereditary angioedema in Sweden
Case Study of Chronic Diarrhea Associated with Alterations in the TOM1 Gene
Comparison of the frequency of viral infections in immunocompromised patients receiving immunoglobulin by different routes
Evolution of Hereditary Angioedema Prophylaxis in Hungary Over Four Decades (1979-2023)
Hereditary Angioedema Burden: Impact on Quality of Life, Disease Management, and Sleep Health
Hereditary angioedema prophylaxis therapy: berotralstat and lanadelumab safety profile
Impact of Berotralstat on Quality of Life among Patients with Hereditary Angioedema: Pooled Analysis of the APeX-2 and APeX-J Trials
Lanadelumab safety and efficacy in patients aged ≥12 with hereditary angioedema (HAE) in China for long-term prophylaxis (LTP): An open-label, multicenter study
Long-Term Safety and Efficacy of Oral Deucrictibant for Prophylaxis in Hereditary Angioedema: Data Snapshot Results of the CHAPTER-1 Open-Label Extension Study
Long-Term Safety and Efficacy of Oral Deucrictibant for Treatment of Hereditary Angioedema Attacks: Results of the RAPIDe-2 Extension Study
Outcome of hematopoietic stem cells transplantation for inborn error of immunity in Vietnam
Patients With HAE Report Positive Perceptions Following Berotralstat Treatment: Results from a Focus Group
Real-World Effectiveness of Lanadelumab in Hereditary Angioedema: A 12-Month Retrospective Study at a Single Center in Colombia
The Effect of Covid-19 Vaccines on Adult Primary Immunodeficiency Patients
The Overlooked Link: Rheumatologic Manifestations in Inborn Errors of Immunity
